Oxycodone/ibuprofen
| Combination of | |
|---|---|
| Oxycodone | Opioid analgesic |
| Ibuprofen | NSAID |
| Clinical data | |
| Trade names | Combunox |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| KEGG | |
Oxycodone/ibuprofen (INNs, trade name Combunox) is an oral combination drug formulation of the opioid analgesic oxycodone and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen that is used in the treatment of chronic and acute pain.[1] This particular drug is supplied in a fixed dose combination tablet which contains Oxycodone Hydrochloride, USP 5 mg with Ibuprofen, USP 400 mg.
Adverse effects
See also
References
- ^ Sinatra RS, de Leon-Cassasola OA (27 April 2009). Acute Pain Management. Cambridge University Press. pp. 198–. ISBN 978-0-521-87491-5.
External links
- "Ibuprofen mixture with oxycodone". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on May 6, 2021.
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams |
|
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
